Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Therapeutic insights into arterial ageing: E2F3 inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins via down regulation of its target gene, 06/February/2015, 23.55, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests that E2F3, by decreasing the expression of its target gene, it may inhibit Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins. Thereby, it may inhibit arterial ageing and ageing associated-cardiovascular diseases. Thus, this study suggests that pharmacological formulations encompassing “E2F3 or its activators“ may be used to prevent arterial ageing.
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Undisclosed information: How E2F3 inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins
Amount: $300*
